89Bio Inc (ETNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 384,656 | 151,204 | 102,249 | 89,743 | 49,355 |
| Operating Income | -384,656 | -151,204 | -102,249 | -89,743 | -49,355 |
| Interest Expense | 5,290 | 4,794 | 1,922 | 674 | 0 |
| Other Income | 23,559 | 17,676 | 2,164 | 148 | -203 |
| Pre-tax Income | -366,387 | -138,322 | -102,007 | -90,269 | -49,558 |
| Income Tax | 692 | 3,867 | 19 | -147 | -59 |
| Net Income Continuous | -367,079 | -142,189 | -102,026 | -90,122 | -49,499 |
| Net Income | $-367,079 | $-142,189 | $-102,026 | $-90,122 | $-49,499 |
| EPS Basic Total Ops | -3.51 | -2.00 | -2.93 | -4.48 | -3.08 |
| EPS Basic Continuous Ops | -3.51 | -2.00 | -2.93 | -4.48 | -3.08 |
| EPS Diluted Total Ops | -3.51 | -2.00 | -2.93 | -4.48 | -3.08 |
| EPS Diluted Continuous Ops | -3.51 | -2.00 | -2.93 | -4.48 | -3.08 |
| EPS Diluted Before Non-Recurring Items | -3.51 | -2.00 | -2.93 | -4.48 | -3.08 |
| EBITDA(a) | $-393,759 | $-156,522 | $-102,400 | $-88,182 | $-48,797 |